PLK1 Blockade Enhances the Anti-Tumor Effect of MAPK Inhibition in Pancreatic Ductal Adenocarcinoma

Researchers conducted a drug library screen on an MEK inhibitor-resistant PDAC model and perform complementary pathway analysis to identify cellular resistance phenotypes.